Transcript Highlights:

• the patient?
• the patient is actually aware?
• the patient is actually aware?
• , because it's unique for each patient.
• Let's keep patients flowing through the... network of that patient because it's unique for each patient

Summary: The Health Care Facilities and System Subcommittee met with a quorum and considered five bills. HB 1101 on out-of-network providers drew the most discussion; Rep. Albert said it would require written notice when a patient is referred to an out-of-network provider and would count certain insurer payments toward deductibles. Several members and the Florida College of Emergency Physicians raised concerns about placing the burden on doctors’ offices, possible delays in referrals, and unclear enforcement, but the bill was reported favorably 16-2. Public testimony included support from AARP and concerns from emergency physicians about ER workflow and insurance-network transparency. The committee then unanimously approved PCS for HB 475, reducing fines for ambulatory surgery centers that violate good-faith estimate requirements from $1,000 to $250 per day, with a lower maximum penalty. The bill sponsor said the change was intended to right-size penalties for smaller facilities; witnesses from surgery centers and HCA supported it. HB 797, which would allow a nonprofit retirement community serving veterans and spouses to create veteran-and-spouse nursing home beds and transfer a certificate of need within 100 miles, also passed unanimously after members discussed whether it could affect access for veterans; the sponsor said it would create additional private beds rather than displace existing ones. HB 1085 on the Children’s Medical Services Program was amended and reported favorably 14-3. The bill would move managed care plan operations for medically fragile children from the Department of Health to AHCA, keep clinical eligibility at DOH, and shift PPEC services fully into managed care. The adopted amendment changed the waiver provision to require AHCA to develop and present a comprehensive redesign plan for the Medicaid model waiver for children receiving private duty nursing. Several members supported the goal but raised concerns about eliminating family choice and the impact on medically fragile children. Finally, HB 1353 on home health care services passed unanimously. The bill would remove geographic limits on home health administrators, allow more licensed RNs including contract RNs to perform visits, and revise the home health excellence award program. Supporters said it would address workforce shortages and improve access, while one member warned it could increase costs and competition for nurses. The committee adjourned after reporting all five bills favorably.

Transcript Highlights:

• I hear the fact that you know the patients very well, your patients very well.
• I had a patient come in.
• We got the patient started on an antibiotic, and the patient went on her way.
• And patients are waiting.
• How many patients? I have 750 patients.

Committee: Senate Health & Human Services

Transcript Highlights:

• These administrative hurdles take physician time away from our patients and can delay patient care.
• without any adverse effects on their patient outcomes.
• The patient doesn't want to substitute.
• because that patient has never been on that medication.
• And some patients will do that.

Committee: Senate Business, Professions and Economic Development

Summary: The Senate Business, Professions and Economic Development Committee heard SB 1094 by Senator Weber Pierson, which would expand pharmacist substitution authority for biosimilars and allow health plans to require use of lower-cost generic or biosimilar alternatives when available, unless the prescriber marks “do not substitute.” The author said the bill is intended to lower prescription drug costs, improve access, and require insurers to report on whether substitutions reduce out-of-pocket costs and premium growth. Committee amendments were accepted, including changes to align definitions with federal law, require a link to the FDA Purple Book, add a 30-day advance notice requirement for plan-driven substitutions, and allow exceptions for patients or providers. Supporters included Blue Shield of California, Sharp HealthCare, health plans, CVS, the California Chamber of Commerce, and other business and health care groups, who argued the bill would increase competition, reduce costs, and remove administrative barriers to using FDA-approved biosimilars. Opponents and “opposed unless amended” witnesses, including the Biotechnology Innovation Organization, the California Rheumatology Alliance, and some physician groups, argued the bill goes beyond current FDA interchangeability standards, could undermine physician judgment, and may create patient safety concerns for some chronic-disease patients who react differently to biosimilars or experience problems with multiple switches. Committee members discussed the “do not substitute” option, patient notification, insurance approval, and whether the bill preserves physician discretion. After debate, Senator Arreguín moved the bill, and the committee voted 10-0 to pass SB 1094 as amended to the Senate Health Committee.

Transcript Highlights:

• I have conducted numerous studies evaluating both my own patients and patients at the national level
• So we want to keep our patients safe.
• This request does not help patients, and it jeopardizes the safety of our Massachusetts patients.
• And I think at the end, the North Story, as patient care, you are responsible for the safety of the patients
• We already have seen these patients, and we're still going to see MassHealth patients.

Committee: Joint Joint Committee on Consumer Protection and Professional Licensure

Summary: The committee opened a hearing of the Joint Committee on Consumer Protection and Professional Licensure focused on health care and human services, reviewed testimony logistics, and then heard a long series of witnesses on several bills. Much of the testimony centered on interstate licensure compacts for dentistry, social work, and occupational therapy, with supporters arguing these compacts would improve workforce mobility, continuity of care, and access while preserving state oversight and public protection. Dental witnesses were split on H.455/S.257, with supporters backing the AADB dental compact for its hands-on exam, background checks, and disciplinary safeguards, while opponents argued a competing compact would better promote portability and avoid conflicts tied to proprietary testing and outside commissions. Social work witnesses strongly supported H.380/S.252, emphasizing continuity of care for clients who move across state lines, reduced costs and delays for practitioners, and the compact’s public-protection features; occupational therapy witnesses similarly supported H.427/S.256, citing access, telehealth, military families, and maintained standards. The committee also heard testimony on S.242, which would expand licensure for lactation care providers. Supporters, including lactation counselors and health center staff, said adding certified lactation counselors and related credentials would expand access, improve breastfeeding support, and allow reimbursement for services now often provided without billing. They described the training required and said the bill would help families, especially in underserved communities. Representative James O’Day also testified in support of the social work compact, and a Council of State Governments witness provided background on compact mechanics and state participation. Another major topic was H.419/S.214 on medical debt. Physicians and researchers testified that cancer patients experience long-lasting medical debt and collections burdens, and they supported limits on the sale and collection of medical debt, bans on reporting it to credit bureaus, and related consumer protections. The hearing also included H.465 on a pathway to special licensure for certain long-term limited-registration dentists serving MassHealth patients, which Representative Senna supported as a way to allow immigrant dentists to practice independently. Finally, the committee heard sharply divided testimony on H.444/S.284, which would allow trained dental hygienists to administer Botox and dermal fillers: supporters framed it as a safe, preventive, and access-expanding tool for TMJ, bruxism, and pain management, while dermatologists opposed it as outside hygienists’ training and a patient-safety risk. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• doctors and patients.
• Our constituents, our patients, my patients need us to show action on this.
• Our constituents, our patients, my patients need us to show action on this.
• category of patient care.
• Number one: patient choice. Patient choice matters. Menopause care is not one-size-fits-all.

Committee: House Health

Summary: The committee heard several health-related bills, with most testimony focused on access to care, patient safety, and health system costs. AB 554 (Prepare Act) would expand and clarify protections for HIV prevention medications, including PrEP and injectable PrEP, by limiting prior authorization and step therapy, extending no-cost coverage requirements, and improving reimbursement for small clinics. Supporters said the bill would protect access amid federal threats to HIV prevention, while insurers opposed it as an expensive mandate that could raise premiums and conflict with state affordability targets. The author argued the bill would prevent infections and preserve California’s existing public health protections. AB 577 would limit health plans and PBMs from restricting physicians’ ability to administer or dispense medications directly to patients when medically necessary. Supporters, including physicians and patient advocates, said the bill would improve continuity of care and prevent delays for vulnerable patients; opponents argued it was too broad, could increase drug costs, and could undermine specialty pharmacy networks. The author said amendments narrowed the bill to in-network providers, required patient consent and cost transparency, and exempted hospital outpatient facilities, but the measure still drew opposition over cost concerns. The committee also heard AB 546, which would require coverage of portable HEPA purifiers for vulnerable enrollees during wildfire emergencies, and AB 224, which would codify California’s updated essential health benefits benchmark plan to add infertility treatment, hearing aids, and expanded durable medical equipment coverage if approved by CMS. AB 1032 would require plans to reimburse additional behavioral health visits for wildfire survivors, and AB 849 would require trained chaperones for sensitive ultrasound exams after testimony about sexual abuse in a hospital setting. AB 1196 would update outdated rules requiring three surgeons for certain heart-lung bypass procedures, and AB 1113 would codify a right to wear a mask for health reasons. AB 1386 would add perinatal care as a required hospital service, but the author said the bill would be amended further to address hospital closures and workforce concerns. Several bills drew support from patient advocates, medical groups, and county officials, while insurers and hospital groups often opposed or sought amendments over staffing, cost, and implementation concerns. Some measures were held pending quorum or were scheduled for later action, and no final votes were taken on the bills discussed in the transcript excerpt.

Transcript Highlights:

• , along with about 170 ALS patients.
• We just want to say thank you for making this real as a patient and patient advocate.
• of our patients like family.
• of our patients like family.
• So right now, if you're a proposed patient, that means you're a Title 36 patient.

Summary: The committee heard House Bill 2433, which would require insurers offering Medicare supplement policies to people 65 and older to also offer them to Medicare beneficiaries under 65 with ALS or end-stage renal disease, with enrollment periods and premium protections tied to 65-year-old rates. Supporters, including dialysis and ALS advocates, said the bill would help a small population facing high out-of-pocket costs and could improve access to transplants and care; opponents argued it would shift costs onto older seniors and raise Medigap premiums. The committee recommended the bill do pass on a 12-0 vote. The committee also heard House Bill 2593, appropriating $1.5 million to the University of Arizona for the Arizona Perinatal Psychiatry Access Line. The sponsor and physicians testified that the line helps obstetric and pediatric providers quickly consult on perinatal depression, postpartum psychosis, suicidality, and other mental health crises, improving outcomes for mothers, children, and families and reducing costly emergency and crisis care. The bill received a do pass recommendation on a 10-1 vote. House Concurrent Resolution 2013, proclaiming June 2026 as Celebrate Life Month, drew emotional testimony from a young woman with spina bifida and another speaker supporting the sanctity of life. Some members objected that the state should focus on practical supports such as paid leave, child care, and health care access, while others supported the resolution as a statement of human dignity. The resolution passed the committee 7-5. The committee then approved House Bill 4010, creating a Board of Genetic Counselors and licensure standards, after testimony from genetic counselors and a patient advocate about the need for qualified counseling and better access; it passed 11-1. Later, the committee approved House Bill 2196, which would require pharmacy benefit managers to reimburse non-affiliated pharmacies at least their acquisition cost and pay a dispensing fee, and establish an appeals process. Independent pharmacists and their coalition said PBM practices are driving closures and unfairly favor affiliated pharmacies, while PBM and employer representatives warned of major cost increases and said the bill would interfere with private contracts; the bill passed 11-1. The committee also adopted a strike-everything amendment to House Bill 2182 requiring insurers and health plans to report claims denial and prior authorization data to DIFI, and then gave the amended bill a 12-0 do pass recommendation. Finally, the committee approved House Bill 2189, directing the Board of Nursing to update rules for licensed health aides and collect annual data, with the sponsor and board staff saying it would help implement routine ventilator care in the home; it passed 12-0. The committee then began hearing House Bill 2404, a strike-everything amendment on inter-facility transports for behavioral health patients, but the transcript cuts off before action on that bill.

Transcript Highlights:

• IT SAYS YOU MUST TREAT A PATIENT WHO IS UNVACCINATED.
• AND HE WOULD BE LIABLE FOR THE PATIENT DOES HE STILL HAVE TO TREAT THAT PATIENT AND EXCEPT HIM EVEN
• ENHANCING PATIENT TREATMENT AND CONTINUITY OF CARE.
• SENATE BILL 1606 IS A PATIENT ACCESS TO RECORDS.
• UNDER THIS BILL THIS PATIENT ATTORNEY WOULD BE ABLE TO ACCESS HER ENTIRE PATIENT PORTAL.

Transcript Highlights:

• low-risk patients that we can care for.
• When a patient is determined to be of a higher risk, that patient is automatically transferred to physician
• It can compromise patient safety.
• Patients deserve it. People deserve that. Patients deserve it. Employees deserve it.
• This bill ensures patients can readily access it.

Summary: The committee heard several health-related bills. AB 1825 by Krell would clarify California’s offenders with mental health disorders program by tightening the standard for determining “substantial danger of physical harm,” improving exit planning, and expanding Medi-Cal access for people released after a successful challenge. Supporters, including psychiatrists, prosecutors, and medical groups, said the bill would close gaps in care and protect public safety; county behavioral health directors and Disability Rights California registered concerns. AB 1696 by Stephanie would state that nurse midwives do not need physician supervision when providing care within their existing scope, including EMTALA-related evaluation in labor and delivery settings. Nurse midwives and nursing groups supported the bill, while emergency physicians opposed it unless amended, arguing emergency department screening should remain under physician supervision; the author said she would keep working on the issue. AB 1949 by Lee would make acupuncture a separate Medi-Cal benefit and allow up to 24 visits per year. The author and supporters from acupuncture, health access, and integrative medicine groups said the current monthly cap is too restrictive and that acupuncture is an effective, cost-saving alternative for pain management and other conditions. There was no opposition. AB 2330 by Patterson would create a distinct regulatory category for cold spas, with standards for construction, operation, and disinfection. Fitness and wellness groups supported the bill, environmental health administrators had no formal position but thanked the author for amendments, and a committee member raised concerns about local officials interpreting the bill to require separate enclosures from saunas; the author said she would continue working on the language. AB 2000 by Aguirre-Curry would limit mid-year changes to prescription drug formularies and add notice, exceptions, reporting, and enforcement provisions. Family physicians, chronic care advocates, nurses, pharmacists, and patient groups supported the bill, citing non-medical switching and treatment disruptions; health plans and insurers opposed it, warning of higher costs, reduced flexibility, and premium increases. AB 1929 by Ortega would require health plans to disclose investments, including in private prisons and immigrant detention centers. Supporters framed it as a transparency measure tied to patient premiums and public values, while opponents argued the bill was duplicative, burdensome, and potentially harmful to investment confidentiality. AB 2746 by Schiavo would classify medical credit card debt as medical debt so it would not appear on credit reports. Consumer advocates and legal aid groups supported the bill, describing abusive marketing and housing harms; banks, debt collectors, and industry groups opposed it as unworkable and privacy-invasive. The committee took roll on AB 2746 and passed it on a due pass motion to Banking and Finance, with several members voting aye and a few no votes recorded.

Transcript Highlights:

• I come from the patient voice.
• The patient doesn't have a choice.
• The patient doesn't have a choice.
• And so we're going to have patient assistance programs.
• patients.

Committee: House Health and Mental Health

Transcript Highlights:

• </c><00:41:02.440><c> be</c><00:41:02.520><c> able</c> patients and have your patients be able patients
• </c><00:42:11.319><c> and</c> patient the choice let's the patient and patient the choice let's the patient
• This should be a patient-and-provider, patient-and-nurse, patient-and-doctor-run health care system.
• This should be a patient-and-provider, patient-and-nurse, patient-and-doctor-run health care system.
• </c><00:47:23.680><c> in</c> provider patient in nurse patient in provider patient in nurse patient in

Committee: Senate Health and Human Services

Transcript Highlights:

• We found that an average patient would have to make six to seven calls to book a new patient appointment
• You give feedback to the patient.
• So, this is what we've learned over many years of looking at why patients sue, what patients want.
• I'm also a patient here, and I am the wife of a patient. ...and I'm the mother of patients here.
• We would see a patient, go to our mentor, and present that patient. patient and learn over time.

Committee: House Legislative Health & Human Services Committee

Transcript Highlights:

• Most of my patients will need lifelong therapy until a cure is found, and some patients are at high risk
• beings who provide patient care.
• It is not a patient safety mechanism.
• I believe the patient would still need to be seen and assessed before you let the patient go.
• We're talking about patient safety.

Summary: The committee heard AB 1887, which would speed prior authorization for FDA-approved rare disease treatments prescribed by specialists and, if a plan does not act within 30 days, deem the request approved. The author and supporters, including patients and clinicians, said delays can cause irreversible harm, hospitalizations, and death, especially for children and people with progressive rare diseases. Health plans and insurers opposed the bill’s automatic-approval provision and said the measure lacked safeguards for incomplete requests and shared responsibility for timely information. The chair encouraged continued work with opponents, and the author said the bill was narrowed from an earlier version that would have waived prior authorization entirely. The committee also heard AB 1979 on artificial intelligence in health care, AB 2161 on Medi-Cal work requirements, AB 539 on extending approved prior authorizations, AB 2311 on physician employment at public hospital districts, AB 1148 on banning phthalates and bisphenols in food packaging, AB 1825 on mental health offender reentry coordination, and AB 2282 on a temporary emergency stabilization unit in Patterson. AB 1979 would preserve licensed clinicians’ professional judgment, bar AI from directing unlicensed clinical functions, and protect medical records used by consumer chatbots; after amendments, several hospital, medical, and industry groups moved from opposition to neutral. AB 2161 would limit the harm of federal Medi-Cal work-reporting rules by using existing data, improving notices, and protecting due process; it drew broad support from patient, provider, and advocacy groups. AB 539 would keep prior authorization approvals valid for up to one year or the course of treatment, with supporters citing continuity of care and opponents warning about utilization, fraud, and cost concerns. AB 2311, as amended, would let certain high-payer-mix or distressed public health care districts directly employ physicians; CMA withdrew opposition after the bill was narrowed, while some hospital interests still objected to the carve-out. AB 1148 would prohibit two chemicals commonly used in food packaging, with supporters citing cancer and endocrine-disruption risks and opponents arguing DTSC should handle the issue through its existing regulatory process. AB 1825 would improve transition planning and Medi-Cal enrollment for offenders with mental health disorders leaving state hospitals, and AB 2282 would authorize a temporary rural emergency stabilization care unit in Patterson until a permanent hospital is built. Several bills were held for later action because the committee lacked a quorum, and the chair repeatedly noted that motions would be taken once enough members returned.

Transcript Highlights:

• </c> bring our patients in. bring our patients in.
• </c> patients deserve. patients deserve.
• </c> these patients. these patients.
• . patients. patients.
• </c> trauma and burn patients. trauma and burn patients.

Bills: HF4841 , HF4234 , HF3697

Committee: House Taxes

Keywords: Hennepin County, sales tax, health care facilities, ballpark improvements, tax revenue, HF4234, Minnesota private activity bonds, tax-exempt bonds, bond cap, aggregate bond limitation, residential rental projects, multifamily housing, affordable housing finance, housing bonds, public finance, bond allocation, private activity bond cap, Minnesota Statutes 474A.02, tax committee, tax refund

Transcript Highlights:

• These administrative hurdles take physician time away from our patients and can delay patient care.
• The most common condition rheumatology patients have is arthritis.
• The patient doesn't want to substitute.
• because that patient has never been on that medication.
• And some patients will do that.

Summary: The Senate Business, Professions and Economic Development Committee heard SB 1094 by Senator Weber Pearson, which would expand pharmacist and health plan authority to substitute biosimilars for reference biologic drugs in order to lower prescription drug costs. The author and supporters, including Blue Shield of California, Sharp HealthCare, and several business and health groups, argued that biologics are a major driver of rising health care spending and that biosimilars can provide substantial savings while maintaining safety and efficacy. The bill also included transparency provisions and committee amendments, including notice requirements and clarifications around substitution and exceptions. Opposition came from the Biotechnology Innovation Organization, the California Rheumatology Alliance, and Biocom, who said the bill was not scientifically justified, could undermine FDA standards, and might lead to unwanted switching, side effects, or delays in care for patients with chronic conditions. They emphasized that pharmacists can already substitute interchangeable biosimilars and that non-interchangeable products can be changed with prescriber contact. Committee discussion focused on patient safety, the meaning of “do not substitute,” the 30-day notice provisions, and the distinction between biosimilars and interchangeable biosimilars. After debate, the committee adopted a due pass as amended motion to the Senate Health Committee. The bill passed the committee on a 10-0 roll call vote and was sent onward.

Transcript Highlights:

• It is time-based, patient-specific, and often very unpredictable.
• profits continue to climb, while patients are left behind.
• It protects patients when surgery does not go according to plan.
• We're a nonprofit patient advocacy organization.
• We've helped approximately 40,000 patients apply for charity care.

Summary: The House Health Care & Wellness Committee held public hearings on several bills. House Bill 2232 would create a Department of Health-operated time-sensitive emergency data repository covering trauma, cardiac, and stroke events, with quality improvement reporting and support for rural facilities; it drew strong support from emergency physicians, nurses, and the Department of Health, while the Washington State Hospital Association said hospitals support the goal but lack the resources to absorb the added requirements. House Bill 1812, as a proposed substitute, would bar insurers and public plans from imposing anesthesia time limits or related reimbursement caps; the sponsor and anesthesia providers said it protects patient safety and fair payment, and the Washington State Society of Anesthesiologists asked for a clarifying amendment on physical status modifiers. House Bill 2250 would limit hospital charity care to Washington residents, while preserving emergency care access; supporters from rural hospitals and the Washington State Hospital Association said the change would help border hospitals facing rising nonresident charity care, and opponents from legal aid, patient advocacy, and LGBTQ groups warned it would create barriers, chill access for immigrants and other vulnerable patients, and conflict with Washington’s safety-net values. The committee also heard House Bill 2340, which would extend existing substance-use monitoring program protections and stipend eligibility to nursing assistants under the Board of Nursing’s CARES program. The sponsor described it as a simple equity measure, and the Board of Nursing supported it, saying it would improve access and reduce stigma; members asked where the stipend funding comes from, and staff and the board said it is currently general-fund supported at about $25,000 annually. House Bill 2577 would change hospital inspection law by requiring acute care hospital inspections every 18 months rather than on average, allowing some accredited inspections to satisfy the requirement every 36 months, and clarifying fire-protection reinspection standards; the sponsor and Department of Health said it responds to a JLARC audit and provides needed clarity, while DOH said it is still working to catch up from inspection delays caused by the public health emergency. The meeting ended after public testimony on the bills was closed and the committee adjourned.

Transcript Highlights:

• Acute care hospitals hold on to patients at up to $1,000 a day, and the patient does not receive the
• This is not the best setting for these patients and poses challenges for providing patients with the
• able and willing to accept the patient.
• Patients may also have to go to a facility that is not... ...there.
• It should also yield a lower cost for the patient.

Summary: The Health Care and Wellness Committee met on February 10 at 8:30 a.m. and heard two bills. On Engrossed Second Substitute Senate Bill 5594, staff explained that the bill would expand state policy on biosimilars by allowing health carriers to require patients to try a biosimilar before covering the equivalent brand drug starting in 2027, directing exchange plans to increase biosimilar utilization, and changing pharmacist substitution rules so substitution is generally allowed unless the prescriber says not to substitute. The prime sponsor, Sen. Harris, said the bill would lower costs and noted many other states already allow similar substitution. Supporters from health plans and generic/biosimilar manufacturers said biosimilars are safe, effective, and can save consumers and the system money, while a patient advocate raised concerns that the bill may not guarantee lower out-of-pocket costs at the pharmacy counter and suggested preferred formulary placement as a fix. AAM supported the bill with a technical amendment to place biosimilars in the same section as generics and interchangeable products, and the hearing on the bill was closed with no vote taken. The committee also heard Engrossed Senate Bill 5142 on Medicaid network adequacy for post-acute care. Staff said the bill would require the Health Care Authority to adopt network adequacy standards for nursing homes and inpatient rehabilitation facilities, considering community access, regional availability, timeliness, and federal Medicaid rules, with standards due by January 1, 2028 and implementation by July 1, 2028. Sen. Muzzall described it as a follow-up to last year’s bill that would create a pre-approved pathway for patients who are difficult to discharge because continuing care is hard to secure. Testimony from hospital and health system representatives strongly supported the bill, saying patients often remain in hospitals longer than medically necessary because of delays in finding skilled nursing or rehab placements and because single-case agreements are time-consuming and unpredictable, especially in rural areas. Public testimony on SB 5142 was then closed, and the meeting adjourned without any recorded votes or other action.

Transcript Highlights:

• low-risk patients that we can care for.
• When a patient is determined to be of a higher risk, that patient is automatically transferred to physician
• Patients and doctors... Insurance plans cover and what patients must pay.
• It can compromise patient safety.
• This bill ensures patients can readily access it.

Committee: House Health

Transcript Highlights:

• Our patient population is very complex.
• Patient number one, I am, let me clarify that I do not, I'm not...
• Patient number one, last week, a patient 75 years old, with a bad heart, weak heart, congestive heart
• the patient to stop the antiarrhythmic drug.
• But diagnosing patients, working with patients, and treating patients who have a health condition as

Committee: Senate Appropriations Committee on Health and Human Services

Summary: The Appropriations Committee on Health and Human Services took up two bills. Senator Burgess presented SB 116, the Senate Veterans Package, which would reduce the number of Veterans Hall of Fame nominations, expand FDVA health survey and coordination efforts, add mental health training to the veterans suicide prevention pilot program, fix statutory references, improve coordination between Veterans Florida and FDVA, and require FDVA to develop a plan for adult day health care facilities for veterans and their families. An amendment was adopted to appropriate $300,000 for the suicide prevention training pilot and $50,000 for the health survey. The bill was supported in debate, especially for the adult day care provision, and CS/SB 116 was reported favorably by roll call vote. The committee then heard SB 294 by Senator Harrell, which would exclude specified cardiac conditions—such as heart failure, coronary heart disease, and cardiac arrhythmias—from the list of chronic health conditions that may be managed under collaborative pharmacy practice agreements. Senator Harrell argued that these complex conditions require direct physician involvement and that pharmacists should not be making medication changes for severe cardiac patients based on protocols alone. Senator Rouson asked why heart conditions had been included previously, and Vice Chair Davis asked about fiscal impact; Harrell said there would be no state cost, though patients might face additional out-of-pocket expenses, which she said could be offset by avoiding more serious complications. Public testimony on SB 294 was divided. The Florida Pharmacy Association opposed the bill, arguing that collaborative practice agreements are voluntary, physician-controlled, and already include safeguards, and that pharmacists are highly trained to help manage chronic conditions and improve access and outcomes. A cardiologist with the Florida Chapter of the American College of Cardiology supported the bill, warning that cardiac patients are complex and that pharmacists may make dangerous decisions without the full clinical picture. Senator Burton also supported the bill, saying the original collaborative practice framework was not intended to let pharmacists diagnose or treat serious cardiac disease. SB 294 was then reported favorably by roll call vote. At the end of the meeting, Senators Rodriguez and Garcia asked to be recorded in the affirmative on SB 116, and the committee adjourned without further business.

Transcript Highlights:

• </c> patients in because a seizure patient patients in because a seizure patient from<00:20:48.320><c
• We take care of our patients. Any patient that's in front of us, we're going to take care of.
• We take care of our patients. Any patient that's in front of us, we're going to take care of.
• </c> patient because that's not what we do. patient because that's not what we do.
• </c> patients and we want the best for them. patients and we want the best for them.

Transcript Highlights:

• SP 294 PATIENT OUTCOMES AND CHRONIC DISEASE MANAGEMENT.
• THESE PATIENTS, OUR POPULATION ARE VERY COMPLEX.
• PATIENT NUMBER ONE LAST WEEK, PATIENTS WITH 75 YEARS OLD, BAD HEART, WEAK HEART, CONGESTIVE HEART FAILURE
• PATIENT GOES TO THE PHARMACY TO GET A PRESCRIPTION, PHARMACY TELLS THE PATIENT THAT IF HE'S TAKING AN
• BUT DIAGNOSING PATIENTS, WORKING WITH PATIENTS AND TREATING PATIENTS WHO HAVE A HEALTH CONDITION AS SERIOUS